Earnings Ahead

GILD - Gilead Sciences Inc

76.42 0.3 0.39

Gilead Sciences Inc

Gilead Sciences Inc

About

Profile

At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world.


Headquarters

Foster City, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

GILD



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Gilead Sciences Non-GAAP EPS of $1.72 misses by $0.04, revenue of $7.12B beats by $20M
  • Gilead set to roll out Q4 results post-market Tuesday
  • Gilead Sciences stock traded in the red for seventh straight session
  • Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more
  • Arcus Biosciences: Did Gilead Sciences overpay for its latest investment?
  • Gilead gets FDA okay for faster Yescarta production process
  • Arcus shares extend gains amid mixed reactions on Gilead stake purchase
  • Gilead invests $320M in Arcus, expands stake to 33%
  • Big Pharma earnings season in spotlight amid positive sentiment
  • PBMs ramp up lobbying efforts amid growing public scrutiny
  • Gilead stands behind benefits of its CAR-T therapies
  • CAR-T therapies to get boxed warning on blood cancer risk
  • Gilead in selloff after late-stage setback for Trodelvy
  • Biggest stock movers today: Boeing, NuStar Energy, Archer-Daniels-Midland, and more
  • Gilead stock drops as Trodelvy fails Phase 3 lung cancer trial
  • Eli Lilly’s Jaypirca to lead BTK inhibitor market for leukemia
  • Arcus posts early-stage data for Gilead-partnered cancer therapy
  • First RSV shots, groundbreaking gene therapy among 2024 drugs to watch
  • Health stocks to watch this earnings season as sector poised for resurgence
  • Gilead must face negligence claims over HIV drug development, court says
Date Price Open High Low Vol Change
Apr 26 65.42 65.5
66.35
64.63
12.4M 0.23%
Apr 25 65.27 67.47
67.9
65.09
15.2M -2.7%
Apr 24 67.08 66.58
67.18
66.36
8.5M 0.07%
Apr 23 67.03 67.09
67.68
67
5.2M 0.12%
Apr 22 66.95 66.93
67.57
66.74
5.6M 0.28%
 
Apr 19 66.76 66.25
66.83
66.16
10.7M 0.91%
Apr 18 66.16 67.01
67.02
65.9
6.4M -1.15%
Apr 17 66.93 67.35
67.55
66.89
5.3M -0.56%
Apr 16 67.31 67.8
67.89
67.18
5.0M -0.65%
Apr 15 67.75 68.27
68.46
67.7
7.7M -0.47%
Apr 12 68.07 68.52
68.62
67.62
5.7M -0.84%
Apr 11 68.65 68.46
69.03
68.31
6.1M 0.78%
Apr 10 68.12 69.76
69.76
68.06
8.0M -2.6%
Apr 9 69.94 69.16
69.95
69.11
5.9M 0.75%
Apr 8 69.42 69.05
69.55
69.05
4.6M -0.23%
Apr 5 69.58 69.69
70.01
68.54
6.6M 0.04%
Apr 4 69.55 71.24
71.39
69.39
7.3M -1.89%
Apr 3 70.89 72
72.17
70.7
5.1M -1.66%
Apr 2 72.09 72.82
72.85
71.9
6.1M -1.08%
Apr 1 72.88 73.22
73.22
72.38
3.7M -0.51%
Mar 28 73.25 73.25
73.87
73.2
8.4M 0.33%
Mar 27 73.01 72.92
73.06
72.55
7.7M 0.83%
Mar 26 72.41 72.32
72.66
72.11
5.4M -0.23%
Mar 25 72.58 72.5
72.84
72.2
5.5M -0.04%
Mar 22 72.61 73.11
73.23
72.56
7.7M -0.66%
Mar 21 73.09 73.9
74.28
73.03
5.8M -1.2%
Mar 20 73.98 73.27
73.98
72.8
7.1M 0.78%
Mar 19 73.41 73.34
73.77
73.19
6.5M 0.20%
Mar 18 73.26 73.69
74.17
73.21
5.4M -0.58%
Mar 15 73.69 74.25
74.66
73.29
13.9M -0.7%
Mar 14 74.21 74.72
75.02
73.82
8.1M -2.28%
Mar 13 75.94 75.49
76.18
74.96
6.0M 1.15%
Mar 12 75.08 75.25
75.34
74.25
5.9M -0.32%
Mar 11 75.32 74.88
76.21
74.83
7.4M 0.27%
Mar 8 75.12 73.96
75.43
73.66
9.5M 1.98%
Mar 7 73.66 72.97
74.08
72.68
9.4M 1.42%
Mar 6 72.63 72.88
73.32
72.51
6.1M -0.49%
Mar 5 72.99 72.4
73.01
72.1
5.9M 1.02%
Mar 4 72.25 72.39
72.6
71.96
5.0M -0.08%
Mar 1 72.31 72.28
72.65
72.04
5.4M 0.29%
Feb 29 72.1 72.72
72.91
71.92
8.5M -0.83%
Feb 28 72.7 73.18
73.25
72.61
4.2M -0.44%
Feb 27 73.02 72.85
73.14
72.63
6.1M 0.10%
Feb 26 72.95 73.5
73.89
72.84
5.2M -0.82%
Feb 23 73.55 73.25
74.24
73
5.6M 1.06%
Feb 22 72.78 72.26
72.89
71.83
7.3M -0.57%
Feb 21 73.2 72.51
73.29
72.51
6.0M 1.61%
Feb 20 72.04 71.59
72.73
71.45
7.7M 0.64%
Feb 16 71.58 73
73.09
71.37
12.8M -2.44%
Feb 15 73.37 73.04
73.57
72.81
5.4M 0.45%
Feb 14 73.04 73.11
73.83
72.83
7.5M -0.67%
Feb 13 73.53 74.69
74.77
72.97
8.5M -1.24%
Feb 12 74.45 73.41
75.14
73.11
7.6M 1.06%
Feb 9 73.67 73.82
74.12
72.81
10.7M -0.18%
Feb 8 73.8 74.4
74.59
73.03
8.6M -0.83%
Feb 7 74.42 76.21
76.45
73.94
12.4M -4.25%
Feb 6 77.72 76.87
77.87
76.71
8.1M 1.32%
Feb 5 76.71 76.65
77.05
76.01
6.4M -0.32%
Feb 2 76.96 77.61
77.99
76.91
7.6M -1.54%
Feb 1 78.16 78
78.58
77.4
7.5M 0%